Outcomes of extended infusion piperacillin/tazobactam for documented Gram-negative infections. Diagnostic microbiology and infectious disease [Diagn Microbiol Infect Dis] Journal article

Title	Outcomes of extended infusion piperacillin/tazobactam for documented Gram-negative infections.
Author(s)	Patel GW, Patel N, Lat A, Trombley K, Enbawe S, Manor K, Smith R, Lodise TP
Institution	Medical Center of Plano, TX 75075, USA.
Source	Diagn Microbiol Infect Dis 2009 Jun; 64(2):236-40.
Abstract	This comparison of intermittent versus extended-infusion piperacillin-tazobactam among patients with Gram-negative infections revealed similar mortality and length of stay. Outcomes remained similar when stratified by MIC value.
Language	eng
Pub Type(s)	Journal Article
PubMed ID	19500529

Advertise on this site.